Introducing Twelve Converter! Real-time currency rates at your fingertips. Available on Android, iOS soon!

ALNY

329.76999 USD
7.71
2.39%
Last update Jul 2, 3:59 PM EDT
Market closed
Day range
319.39999
330
Previous close
322.059998
Open
319.62000
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
329.77
7.71
2.39%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 2.2B 1.8B 1.0B 844.3M
Cost of revenue 323.4M 310.4M 168.8M 140.1M
Gross profit 1.9B 1.5B 868.6M 704.1M
Operating expense
Research & development 1.1B 1.0B 883.0M 792.2M
Selling general and admin 975.5M 795.6M 770.7M 620.6M
Other operating expenses
Operating income -176.9M -282.2M -785.1M -708.7M
Non operating interest income
Income 122.0M 95.6M 24.8M 1.6M
Expense 141.9M 121.2M 156.0M 143.0M
Other income expense -180.6M -125.7M -210.8M -2.1M
Pretax income -377.4M -433.5M -1.1B -852.1M
Tax provision -99.2M 6.7M 4.2M 680K
Net income -278.2M -440.2M -1.1B -852.8M
Basic EPS -3.5 -9.3 -7.2
Diluted EPS -3.5 -9.3 -7.2
Basic average shares 124.9M 121.7M 118.5M
Diluted average shares 124.9M 121.7M 118.5M
EBITDA -5.1M -107.3M -680.9M -636.7M
Net income from continuing op. -278.2M -440.2M -1.1B -852.8M
Minority interests
Preferred stock dividends
Market closed

Exchange is currently closed
Pre-market opens in 4 days 6 hours 10 minutes

21:49
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).